Compare OPAD & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPAD | PYXS |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | 140 | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5M | 82.3M |
| IPO Year | N/A | 2021 |
| Metric | OPAD | PYXS |
|---|---|---|
| Price | $0.65 | $1.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $1.83 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 688.4K | 295.2K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,858,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $32.08 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.57 | $0.84 |
| 52 Week High | $6.35 | $5.55 |
| Indicator | OPAD | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 37.61 | 47.66 |
| Support Level | N/A | $1.29 |
| Resistance Level | $0.82 | $1.69 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 29.22 | 37.80 |
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.